Opioid Withdrawal Management Market Overview
Opioid withdrawal management, is the treatment with drugs to manage and reduce the intensity of bio physiological withdrawal symptoms associated with dependence or addiction to opioids and to reduce the chances of relapse. Addiction is the compulsive and uncontrollable use of drugs for non-medical uses despite adverse consequences. Dependence is the adaption of body to the presence of a drug, resulting in withdrawal symptoms when drug use is discontinued. The physiological opioid withdrawal symptoms include Muscle aches, pain, spasms, Involuntary movements, Mild hypertension, and others. The psychological opioid withdrawal symptoms include agitation, anxiety, panic, restlessness, rapid heart rate, seizures, fear, paranoia and others. Thus opioid withdrawal management aids the patient to avoid relapsing and to quit opioid addiction and dependence with minimal discomfort.
Opioid Withdrawal Management Market: Drivers and Restraints
The explosive use of opioids for management of pain, opioid abuse resulting from illegal use coupled with the perverse incentives and misdirection by pharmaceutical pain management companies are the driving factors for the market. The National Institute on Drug Abuse and the Centers for Disease Control and Prevention, have declared that the U.S. is in the midst of an opioid epidemic. U.S. consumes about 80% of global opioids although it has less than 5 % of the world’s population. Concerns about Opioid overdose related deaths which accounted for 49,000 of the 72,000 drug overdose deaths in the U.S. in 2017 alone has generated a lot of market enthusiasm. According to the center of disease control, around 66% of the more than 63,600 drug overdose deaths in 2016 involved an opioid and on average, 115 Americans die every day from an opioid overdose
This has resulted in a cry from the media resulting in growing stringency of regulations. According to the center of disease control, the sharpest increase among the 72,000 drug overdose deaths in 2017, were related to fentanyl and analogs at nearly 30,000. The development of withdrawal clinics and the growing success of opioid withdrawal treatment especially the development of non-opioid drugs for the treatment and mitigation of opioid withdrawal symptoms is driving a faster adoption. Work place policies such as zero tolerance policies for substance abuse, regular check-ups and screening is another driver of the market.
The unfortunate reality of the prospering drug trade traversing international borders, the spread of heroin abuse has further stimulated the market. According to the national institute of drug abuse, almost 2.1 million people in the U.S. suffer from prescription opioid pain medicines related substance use disorder related in 2016 with only 17.5 percent receiving treatment.
A large market enthusiasm has been generated by the approval of lofexidine, the first drug intended for reducing symptoms associated with opioid withdrawal by the U.S. Food and Drug Administration. However, the social stigma associated with opioid addiction, discriminating and strict workplace rules and the lower success rate of Opioid withdrawal management is hampering the market.
Opioid Withdrawal Management Market: Overview
The global market for opioid withdrawal management is expected to charge owing to growing stringency of regulations. For example, on 12 December 2006, the U.S. President signed the Bill H.R.6344, under which the physician holding rights to prescribe opioid would have to provide opioid dependence treatment to up to 100 patients (previously 30). Medicare, Medicaid, and other government organizations pay or supplemented payments for opioid withdrawal management treatment in almost 80% of the population. Private health insurance supplements the remaining 30% of the population. Togeather they account for large market equity for the players operating in the opioid withdrawal management market. The market trends include a definite shift in favor of developing regions of Asia Pacific, such as India and China.
For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7672
Opioid Withdrawal Management Market: Market Participants
Some of the major vendors operating in the global opioid withdrawal management market are Alkermes, Inc., Orexo AB, Ethypharm, Indivior PLC, Mylan Pharmaceuticals Inc., Sun Pharmaceutical Industries, Inc., Teva Pharmaceuticals USA, Inc., Dr. Reddy’s Laboratories, Indivior PLC, BioDelivery Sciences International , Inc., Rhodes Pharmaceuticals L.P., Hikma Pharmaceuticals USA Inc., Actavis Elizabeth LLC, Mallinckrodt Pharmaceuticals and others.
The global opioid withdrawal management report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The opioid withdrawal management report covers exhaustive analysis on,
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes,
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K., Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest of Eastern Europe)
- Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-7672
About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com